flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the ADA 24: FLOW Trial: Kidney
Description
Stop Before Full: Try to eat until you are satisfied, not completely full, to minimize discomfort
If youre on an SSRI, SNRI, or any other serotonergic medication: the drug interaction issue is the main constraint
Generally, a decrease in blood pressure is a positive sign of improved cardiovascular health and reduced strain on your heart
DRI Calculator for Healthcare Professionals
This single-pathway approach has proven effective for millions of patients since its introduction
Improved energy and mobility may reduce the need for assistance or mobility aids
